¼¼°èÀÇ ½Å°æº¸Ã¶ ½ÃÀå - ¿¹Ãø(2024-2029³â)
Global Neuroprosthetics Market - Forecasts from 2024 to 2029
»óǰÄÚµå : 1495976
¸®¼­Ä¡»ç : Knowledge Sourcing Intelligence
¹ßÇàÀÏ : 2024³â 04¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 130 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,950 £Ü 5,619,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,550 £Ü 6,472,000
PDF (Multiple User License) help
PDF º¸°í¼­¸¦ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,887,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

½Å°æº¸Ã¶ ½ÃÀåÀº 2022³â 40¾ï 5,200¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, ¿¬Æò±Õ 12.36% ¼ºÀåÇÏ¿© 2029³â¿¡´Â 91¾ï 2,400¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½Å°æº¸Ã¶Àº ½Å°æÀÌ ¼Õ»óµÈ ȯÀÚ¿¡°Ô À̽ÄÇÏ¿© ½Å°æÀÇ Á¤»óÀûÀÎ ±â´ÉÀ» º¸¿ÏÇϰí ȸº¹½ÃÄÑ Á¤»óÀûÀÎ ½Åü ±â´ÉÀ» ºÎºÐÀûÀ¸·Î ȸº¹ÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â ÀåÄ¡ÀÔ´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î ½Å°æ Àå¾ÖÀÇ Áõ°¡´Â ¿¹Ãø ±â°£ µ¿¾È ½Å°æº¸Ã¶ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ÀÌ ½ÃÀå¿¡´Â ³ú-±â°è ÀÎÅÍÆäÀ̽º, ô¼ö Àڱرâ, Àΰø¿Í¿ì, ³ú½ÉºÎÀڱرâ, ¸Á¸· ÀÓÇöõÆ® µî ´Ù¾çÇÑ Á¾·ùÀÇ ÀåÄ¡°¡ Æ÷ÇԵ˴ϴÙ. ÁÖ¿ä ÁøÀÔ ±â¾÷À¸·Î´Â ±âÁ¸ ÀÇ·á±â±â ±â¾÷°ú ½Å»ý º¥Ã³±â¾÷ÀÌ ÀÖ½À´Ï´Ù.

FDA³ª EMA¿Í °°Àº º¸°Ç ´ç±¹ÀÇ ±ÔÁ¦ ½ÂÀÎÀº ¾ÈÀü¼º°ú À¯È¿¼ºÀ» º¸ÀåÇÕ´Ï´Ù. ±â¼úÀû °úÁ¦·Î´Â º¹ÀâÇÑ ½Å°æ ³×Æ®¿öÅ©¿ë ÀåÄ¡ °³¹ß, À±¸®Àû °í·Á»çÇ×, ÇÁ¶óÀ̹ö½Ã ¹®Á¦, »çȸÀû ¼ö¿ë¼º µîÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ´ç´¢º´ ȯÀÚÀÇ Áõ°¡·Î ÀÎÇØ ¸¹Àº »ç¶÷µéÀÌ ½Å°æ ¼Õ»óÀ» ÀÔ¾î ÇâÈÄ ¸î ³â µ¿¾È ½Å°æº¸Ã¶¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ³­Ã» ȯÀÚ ¼ö´Â ¼ö³â µ¿¾È Å©°Ô Áõ°¡ÇßÀ¸¸ç ÇâÈÄ ¸î ³â µ¿¾È ±ÞÁõÇÒ °ÍÀ¸·Î ¿¹»óµÊ¿¡ µû¶ó Æò°¡ ±â°£ µ¿¾È ½Å°æº¸Ã¶ ½ÃÀåÀÇ ¼ºÀåÀÌ ´õ¿í °¡¼ÓÈ­µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀå ÃËÁø¿äÀÎ:

½Å°æÀå¾Ö¸¦ ¾Î°í ÀÖ´Â »ç¶÷µéÀÇ ¼ö´Â Àü ¼¼°èÀûÀ¸·Î Áõ°¡ÇÏ´Â Ãß¼¼À̸ç, ÀÌ´Â ¿¹Ãø ±â°£ µ¿¾È ½Å°æº¸Ã¶¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â µÎµå·¯Áø ÀÌÀ¯ Áß ÇϳªÀÔ´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é, Áö³­ 30³â°£ ½Å°æ Àå¾Ö·Î ÀÎÇÑ »ç¸ÁÀÚ ¼ö´Â 39% °¡±îÀÌ Áõ°¡Çß½À´Ï´Ù. ¶ÇÇÑ, ½Å°æ Àå¾Ö ȯÀÚ ¼ö´Â ¸Å³â Áõ°¡Çϰí ÀÖÀ¸¸ç, ³ëÀÎ Àα¸ÀÇ Áõ°¡, ¼Ò¾Æ »ç¸Á·ü °¨¼Ò, »ýÁ¸À² ¹× ±â´ë ¼ö¸í Áõ°¡·Î ÀÎÇØ ȯÀÚ ¼ö´Â ¾ÕÀ¸·Î ´õ¿í Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¹ü¹Ìº¸°Ç±â±¸(PAHO) ÀÚ·á¿¡ µû¸£¸é, Àα¸ 10¸¸ ¸í´ç Àå¾Ö·Î ÀÎÇÑ »ýÁ¸¿¬¼ö(YLDs)´Â ºê¶óÁúÀÇ °æ¿ì 2010³â 784.06³â¿¡¼­ 2019³â 813.74³âÀ¸·Î Áõ°¡ÇÏ¿´½À´Ï´Ù. ¸ß½ÃÄÚ¿¡¼­´Â 2010³â 721.78³â¿¡¼­ 2019³â 737.02³âÀ¸·Î Áõ°¡Çß½À´Ï´Ù. ¹Ì±¹¿¡¼­´Â 2010³â Àα¸ 10¸¸ ¸í´ç 39.29¸í¿¡¼­ 2019³â 47.39¸íÀ¸·Î 20% ÀÌ»ó Áõ°¡ÇØ ½Å°æÁúȯÀ¸·Î ÀÎÇÑ »ç¸ÁÀÚ ¼ö°¡ Áõ°¡Çß½À´Ï´Ù.

¶ÇÇÑ ¾ËÃ÷ÇÏÀ̸Ӻ´, Ä¡¸Å, ÆÄŲ½¼º´°ú °°Àº Áúº´Àº ºü¸£°Ô È®»êµÇ°í ÀÖ´Â ½Å°æÁúȯ Áß ÀϺÎÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, PAHO¿¡ µû¸£¸é ij³ª´ÙÀÇ °æ¿ì Àα¸ 10¸¸ ¸í´ç Àå¾Ö Á¶Á¤ »ýÁ¸³â¼ö(DALY)°¡ 2010³â 351.30¿¡¼­ 2019³â 415.70À¸·Î 18% ÀÌ»ó ±ÞÁõÇß½À´Ï´Ù.

½Å°æ º¸Ã»±â´Â ÁßÁõ ³­Ã»¿¡ »ç¿ëµÇ±â ¶§¹®¿¡ Àü ¼¼°è ³­Ã» À¯º´·üÀÇ Áõ°¡´Â ÇâÈÄ ¸î ³â µ¿¾È ½Å°æº¸Ã¶ ½ÃÀåÀÇ ¼ºÀåÀ» Áõ°¡½Ãų °ÍÀ¸·Î ¿¹»óµÇ´Â Áß¿äÇÑ ¿äÀÎÀ¸·Î, WHOÀÇ µ¥ÀÌÅÍ¿¡ µû¸£¸é ºê¶óÁúÀÇ Àý´ëÀûÀÎ ³­Ã» ȯÀÚ ¼ö´Â 2008³â 1,000¸¸ ¸í¿¡¼­ 2018³â 1,300¸¸ ¸íÀ¸·Î Áõ°¡Çß½À´Ï´Ù.

Áß±¹¿¡¼­´Â 2008³â 7,400¸¸ ¸í¿¡¼­ 2018³â 9,600¸¸ ¸íÀ¸·Î, Àεµ¿¡¼­´Â 2008³â 7,650¸¸ ¸í¿¡¼­ 2018³â 1¾ï ¸íÀ¸·Î Áõ°¡ÇßÀ¸¸ç, WHO´Â 2020³â 4¾ï 3,000¸¸ ¸í¿¡¼­ 2050³â 7¾ï ¸íÀ» ³Ñ¾î¼³ °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ½Å°æº¸Ã»±â ¼ö¿ä°¡ Å©°Ô ±ÞÁõÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÌ Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Áö¸®ÀûÀ¸·Î ¾Æ½Ã¾ÆÅÂÆò¾çÀº ½Å°æ Àå¾Ö ȯÀÚ ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ¾çÁúÀÇ ÀÇ·á ½Ã½ºÅÛÀÌ Á¸ÀçÇϰí ȯÀÚ Á¢±Ù¼ºÀÌ ¿ëÀÌÇÏ¿© Áø´Ü°ú Ä¡·á°¡ ´õ¿í °ß°íÇÏ°Ô ÀÌ·ç¾îÁö°í ÀÖ´Â °Íµµ ÀÌ Áö¿ªÀÇ ½Å°æº¸Ã¶ ½ÃÀå ±Ô¸ð°¡ Å« ÀÌÀ¯ Áß ÇϳªÀÔ´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼­´Â ³­Ã» À¯º´·üÀÇ Áõ°¡·Î ÀÎÇØ »ó´çÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

¶ÇÇÑ, WHOÀÇ µ¥ÀÌÅÍ¿¡ µû¸£¸é ³²¾Æ½Ã¾ÆÀÇ Àå¾Ö¸¦ µ¿¹ÝÇÑ ³­Ã» ȯÀÚ ¼ö´Â 2018³â 1¾ï 3,100¸¸ ¸í¿¡¼­ 2030³â 1¾ï 7,600¸¸ ¸í, 2050³â¿¡´Â 2¾ï 6,700¸¸ ¸íÀ¸·Î ´Ã¾î³¯ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¶ÇÇÑ, ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼­´Â ´ç´¢º´ ȯÀÚ°¡ ±ÞÁõÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ¸¹Àº ȯÀÚÀÇ ½Å°æ ¹× Ç÷°ü ¼Õ»óÀ¸·Î À̾îÁ® Æò°¡ ±â°£ µ¿¾È ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½Å°æ º¸Á¶±â ¼ö¿ä´Â ´õ¿í ±ÞÁõÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÁÖ¿ä °³¹ß

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå ¿ªÇÐ

Á¦5Àå ½Å°æº¸Ã¶ ¼¼°è ½ÃÀå : À¯Çüº°

Á¦6Àå ½Å°æº¸Ã¶ ¼¼°è ½ÃÀå : ±â¼úº°

Á¦7Àå ½Å°æº¸Ã¶ ¼¼°è ½ÃÀå : ¿ëµµº°

Á¦8Àå ½Å°æº¸Ã¶ ¼¼°è ½ÃÀå : Áö¿ªº°

Á¦9Àå °æÀï ȯ°æ°ú ºÐ¼®

Á¦10Àå ±â¾÷ °³¿ä

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global neuroprosthetics market is evaluated at US$4.052 billion for the year 2022 and is projected to grow at a CAGR of 12.36% to reach the market size of US$9.124 billion by 2029.

Neuroprosthetics are devices implanted in patients with neural damage to compensate for and restore the normal functioning of the nerves, which consequently help in partially restoring normal bodily functions. The rising incidences of neurological disorders worldwide are one of the major factors anticipated to boost the global neuroprosthetics market growth during the forecast period. The market includes various types of devices, such as brain-machine interfaces, spinal cord stimulators, cochlear implants, deep brain stimulators, and retinal implants. Key players include established medical device companies and emerging startups.

Regulatory approvals from health authorities like the FDA and EMA ensure safety and efficacy. Technological challenges include developing devices for complex neural networks, ethical considerations, privacy issues, and societal acceptance. Furthermore, the growing number of diabetes patients, leading to nerve damage in many people, is also expected to lead to a surge in demand for neuroprosthetics in the coming years. Moreover, the number of people with disabling hearing loss has been increasing substantially over the years, and its projected rapid rise in the coming years is further anticipated to augment the global neuroprosthetics market growth during the assessment period.

Market Drivers:

The number of people suffering from neurological disorders is on the rise worldwide and is one of the prominent reasons anticipated to drive the demand for neuroprosthetics during the forecast period. According to the World Health Organization, the number of deaths caused by neurological disorders has increased by nearly 39% in the last 30 years. It has also been stated that an increase in the number of patients with neurological disorders has been seen over the years, while the number of cases is further projected to grow in the coming years owing to a growing elderly population, a decrease in child mortality, and rise in the survival rate and life expectancy.

As per data from the Pan America Health Organization (PAHO), the years lived with disability (YLDs) per 100,000 population in Brazil increased from 784.06 years in 2010 to 813.74 years in 2019. In Mexico, it increased from 721.78 years in 2010 to 737.02 years in 2019. In the United States, the deaths from neurological disorders increased from 39.29 deaths per 100,000 population in 2010 to 47.39 deaths in 2019, witnessing an increase of more than 20%.

Furthermore, diseases such as Alzheimer's, dementia, and Parkinson's disease are some of the neurological disorders spreading fast. For instance, according to PAHO, Canada has witnessed a surge in disability-adjusted life years (DALYs) per 100,000 population from 351.30 in 2010 to 415.70 in 2019, growing by more than 18%.

As neuroprosthetics are used in severe hearing loss, the increasing prevalence of hearing loss worldwide is a significant factor expected to augment the global neuroprosthetics market growth in the coming years. According to data from the WHO, the absolute number of people with hearing loss in Brazil has increased from 10 million in 2008 to 13 million in 2018.

In China, the number of people with hearing loss increased from 74 million in 2008 to 96 million in 2018, while in India, this number increased from 76.5 million in 2008 to 100 million in 2018. WHO has projected that people with disabling hearing loss will increase from 430 million in 2020 to more than 700 million by 2050. This is expected to surge the demand for neuroprosthetics significantly.

Asia Pacific region is projected to have a major market share.

Geographically, the Asia Pacific region is anticipated to hold a significant market share owing to the rising cases of neurological disorders in the region. Furthermore, the presence of a quality healthcare system and its accessibility to patients make diagnosis and treatment stronger, which is another prominent reason for the large market size of neuroprosthetics in the region. The Asia Pacific region is anticipated to witness substantial growth due to the rising prevalence of hearing loss in the region.

Additionally, according to data from the WHO, the absolute number of people with disabling hearing loss in South Asia is projected to increase from 131 million in 2018 to 176 million in 2030 and further to 267 million in 2050. Furthermore, the rapidly growing cases of diabetes in the region are leading to damage to the nerves and blood vessels of a large number of patients, which is further projected to surge the demand for neuroprosthetics in the Asia Pacific region during the assessment period.

Key Developments:

Market Segmentation:

By Type

By Technique

By Application

By Geography

TABLE OF CONTENTS

1. INTRODUCTION

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

5. GLOBAL NEUROPROSTHETICS MARKET BY TYPE

6. GLOBAL NEUROPROSTHETICS MARKET BY TECHNIQUE

7. GLOBAL NEUROPROSTHETICS MARKET BY APPLICATION

8. GLOBAL NEUROPROSTHETICS MARKET BY GEOGRAPHY

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

10. COMPANY PROFILES

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â